Page 119 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 119
Workflow optimization of MTV in DLBCL
Funding Information.
The PETRA study is supported by the Alpe d’HuZes/KWF fund, provided by the Dutch Cancer Society (#VU2012-5848). Alpe d’HuZes/KWF did not have any role in the study design, data collection, analysis, interpretation, and writing of the manuscript.
117
5
